Epharmacy Market Size, Share, Trend & Forecast from 2023 to 2030

Epharmacy Industry Overview

The global ePharmacy market size was valued at USD 60.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20.4% from 2023 to 2030. Rising penetration of the internet across the globe, improving digitalization of healthcare services, and an increasing number of tech-savvy consumers are the key factors boosting the market growth. Rising consumer preference for online purchases with an increased focus on convenience is also aiding the growth. The increasing adoption of digital technologies and e-commerce in the healthcare sector is anticipated to propel overall growth. In January 2022, Mark Cuban, the venture capitalist, launched a digital pharmacy that sells more than 100 generic pharmaceuticals at a low cost, to be radically transparent. ePharmacy offers easier access that significantly benefits chronic elderly patients from nuclear families, as well as patients that are not in a condition to go out.

Increasing penetration of smartphones is further aiding the market growth. As per The Mobile Economy 2020, smartphone penetration was 65.0% in 2019 and is expected to reach 80.0% by 2025. The boom in the healthcare sector coupled with high operational costs has created the need to cut operational costs with the implementation of ePharmacy solutions. The increasing prevalence of chronic conditions is leading to a rise in the demand for various healthcare products, including drugs. This signifies the increasing penetration of online modes of drug procurement across the globe.

Gather more insights about the market drivers, restrains and growth of the Epharmacy Market

Detailed Segmentation:

Regional Insights

North America accounted for the largest market share of over 40.4%% in 2022. Rising adoption of e-commerce, growing geriatric population, increasing online sales, developed healthcare infrastructure, and positive attitude towards the adoption of new technologies are some of the major factors contributing to the regional market growth. Moreover, nearly 80% population of the U.S. is connected to ePharmacy and the shifting trend toward the direct-to-patient model.

The digital world has opened doors to consumer-friendly online experiences and other advanced services is further propelling the overall market growth in North America. As a result, in December 2020, Medicure Inc., the cardiovascular pharmaceutical business, announced that the company has entered into a formal agreement to purchase 100% of Marley Drug, Inc. through its wholly-owned U.S. subsidiary, Medicure Pharma Inc. The COVID-19 pandemic has significantly impacted the purchasing behavior of consumers, leading to more people than ever seeking medicines and other healthcare-related supplies through the ePharmacy platform. For instance, in April 2022, Walgreens and Wing launched drone delivery in the first large urban region in the U.S. as a pilot study.

Asia Pacific is anticipated to register the fastest CAGR during the forecast period. Emerging economies, such as China and India, possess high growth potential owing to the large population base coupled with increasing government initiatives supporting the adoption of digital technologies. With an increase in the number of strategic initiatives by various public and private organizations, the market in Asia Pacific is anticipated to grow at a faster pace in the coming years. For instance, in August 2020, Reliance Retail announced the acquisition of a 60.0% equity stake in Netmeds for USD 83.0 million. The acquisition is aimed at enhancing the company’s ability to offer affordable high-quality health care products services to its customers.

Moreover, in January 2022, Hyphens Pharma International Limited, Singapore's largest specialty pharmaceutical as well as consumer healthcare company, launched WellAway ePharmacy in the city-state. WellAway offers customers the ease of access to pharmaceutical services while also assisting doctors with teleconsultation. This service is especially beneficial for patients who are elderly, immobile, self-isolating, or just desire to limit their external contact time, particularly during the current COVID-19 outbreak.

Browse through Grand View Research's Category Healthcare IT Industry Research Reports.

· The global post-marketing pharmacovigilance and medical information market size was valued at USD 5.60 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

· The global medical animation market size was valued at USD 396.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 20.1% from 2024 to 2030.

Key Epharmacy Companies:

Key players implement various marketing strategies to gain a competitive edge and increase their share. In addition, the companies also implement strategies, such as mergers, acquisitions, and partnerships, for increasing their market share.

Some prominent players in the global ePharmacy market include:

The Kroger Co.
Walgreen Co.
Giant Eagle, Inc.
Walmart, Inc.
Express Scripts Holding Company
CVS Health
Optum Rx, Inc.
Rowlands Pharmacy
DocMorris (Zur Rose Group AG)
Cigna Corporation (Express Scripts Holdings)
com Inc.
Axelia Solutions (Pharmeasy)
Apex Healthcare Berhad (Apex Pharmacy)
Apollo Pharmacy
Netmeds

ePharmacy Market Segmentation

Grand View Research has segmented the global ePharmacy market based on drug type, and region:

ePharmacy Drug type Outlook (Revenue, USD Million, 2017 - 2030)

Prescription drug
Over-the-counter drug (OTC)

ePharmacy Regional Outlook (Revenue, USD Million, 2017 - 2030)

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- Italy
- Spain
- France
- Russia
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- South Korea
- Thailand
Latin America
- Brazil
- Mexico
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait